7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
A critical analysis of SURMOUNT-4's enrollment biases, follow-up duration, generalizability gaps, statistical caveats, and conflict-of-interest considerations for tirzepatide weight maintenance.
A detailed breakdown of the SURMOUNT-4 trial design, randomized withdrawal methodology, estimand framework, and statistical choices that shaped tirzepatide's weight-regain data.
Health-economic analysis of tirzepatide continuation vs discontinuation from SURMOUNT-4, including cost per QALY estimates, payer coverage dynamics, and individual value calculations.
Deep-dive into SURMOUNT-4 follow-up findings on tirzepatide weight regain after discontinuation, durability of effect, and long-term safety signals from the 2024 JAMA trial.
A granular breakdown of SURMOUNT-4 trial results for tirzepatide, including primary and secondary endpoint data with confidence intervals, weight-regain kinetics on placebo switch, and response distribution across subgroups.
Deep-dive into SURMOUNT-4 pre-specified and post-hoc subgroup analyses for tirzepatide weight maintenance, examining differential responses by age, sex, BMI, race, and baseline biomarkers.
Deep-dive into SURMOUNT-4's clinical implications for tirzepatide prescribing: weight regain data, guideline updates, and what the trial means for real-world patients.